Triple-negative breast cancers and the human mammary epithelial cell hierarchy

Shridar Ganesan1, Vassiliki Karantza, Jay Oza

  • 1Cancer Institute of New Jersey, Robert Wood Johnson Medical School-UMDNJ, New Brunswick, NJ 08903, USA. ganesash@umdnj.edu

Breast Disease
|November 3, 2011
PubMed

Insights

Triple-negative breast cancers (TNBCs) are aggressive and diverse. Research links distinct TNBC subtypes to specific mammary stem cell populations, offering insights into their development.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Genomics

Background:

  • Triple-negative breast cancers (TNBCs) lack estrogen/progesterone receptors and HER2 amplification.
  • TNBCs represent an aggressive and heterogeneous group of breast cancers.
  • Previous studies indicate distinct TNBC subsets based on gene expression.

Purpose of the Study:

  • To review recent data on human mammary stem cell hierarchy.
  • To explore the relationship between mammary stem cells and TNBC pathogenesis.
  • To understand the origins of distinct TNBC subclasses.

Main Methods:

  • Gene expression profiling of TNBC samples.
  • Comparative analysis of gene expression data.
  • Characterization of human mammary stem cell hierarchy.

Main Results:

  • Gene expression profiling identified distinct TNBC subsets.
  • Analysis suggests TNBC subclasses originate from specific mammary progenitor cells.
  • Mammary stem cell hierarchy characterization provides insights into TNBC origins.

Conclusions:

  • Distinct TNBC subsets are linked to specific mammary progenitor cell populations.
  • Understanding mammary stem cell hierarchy is crucial for TNBC pathogenesis.
  • This review highlights the role of stem cells in TNBC diversity.